In the News
CHCWM clinical trial published in esteemed medical journal
10/09/2019
One of the oldest, most prestigious medical journals, The Lancet, recently published AstraZeneca’s Phase III CASPIAN trial, of which Cancer and Hematology Centers of Western Michigan (CHCWM) was a leading site. CASPIAN showed that Imfinzi (an anti-PDL1 immunotherapy from AstraZeneca), in combination Read more »
CHCWM’s Yuanbin Chen, M.D., Ph.D. author of working group guideline detailing liquid biopsy for lung cancer
10/04/2019
Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Dr. Yuanbin Chen, M.D., Ph.D. is one of six authors of “Incorporating Liquid Biopsy into Routine Practice for Patients with aNSCLC: A Practical Guideline for Community Oncologists from the Liquid Biopsy Read more »
CHCWM/START Midwest participate in three clinical trials presented at 2019 World Conference on Lung Cancer
09/16/2019
Cancer & Hematology Centers of Western Michigan (CHCWM) and START Midwest were involved in three groundbreaking clinical trials that were presented at the International Association for the Study of Lung Cancer (IASLC)’s 2019 World Conference on Lung Cancer (WCLC) in Read more »
New Muskegon location featured on Wood TV8
08/27/2019
CHC’s new Muskegon location was featured on Wood TV8 yesterday, August 26th. To see the feature and CHC’s Dr. Kathryn Alguire speaking about our state-of-the-art site, click the link below. Watch the Video Read more »
CHC’s Bone Health Clinic featured on WoodTV8
08/06/2019
CHC’s Bone Health Clinic was featured on Wood TV 8 yesterday, August 5th. To see the episode and Tanya Rowerdink, NP – our Director of Multispecialty Services – speaking about all the wonderful work done there, click the link below. Read more »
CHC’s Dr. Sreenivasa Chandana Published in The Journal of Gastrointestinal Oncology
06/27/2019
CHC’s Dr. Sreenivasa Chandana was recently published in the Journal of Gastrointestinal. The article, titled Survival Trends of Metastatic Small Intestinal Neuroendocrine Tumor: A Population-Based Analysis of SEER Database aims “to analyze survival trends in metastatic SNET patients stratified by Read more »